SCHEMBL4783735

SCHEMBL4783735

O=C(c1ccc(-c2cc3nccc(Oc4ccc([AsH2])cc4F)c3s2)cc1)N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MET P08581 19/20 0.48
KDR P35968 18/20 0.48
MST1R Q04912 5/20 0.46
BRD4 O60885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2282590 0.90 MET (0.48) METKDRMST1RBRD4
SCHEMBL12376910 0.82 MET (0.60) METKDRMST1R
SCHEMBL2533739 0.82 MET (0.51) METKDRMST1R
SCHEMBL2539124 0.81 MET (0.48) METKDRMST1R
SCHEMBL2282864 0.80 MST1R (0.51) METKDRMST1R
SCHEMBL2282327 0.80 MET (0.41) METKDRMST1RBRD4
SCHEMBL2282585 0.79 MET (0.49) METKDRMST1R
SCHEMBL2285261 0.78 MET (0.58) METKDRMST1R
SCHEMBL2354715 0.78 MET (0.57) METKDRMST1R
SCHEMBL2282452 0.78 MET (0.55) METKDRMST1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989211-A2 HETEROBICYCLIC THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER Array Biopharma, Inc. (US) 2008-11-12 EP disclosed
WO-2008063202-A2 HETEROBICYCLIC THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER ARRAY BIOPHARMA INC. (US) 2008-05-29 WO disclosed